The Ministry of Health (MOH) has agreed to grant additional indication approval for the product Evusheld 100 milligrammes per millimetre (mg/ml) Solution for Injection (Tixagevimab 100 mg/ml and Cilgavimab 100 mg/ml) manufactured by Astrazeneca AB of Sweden.
Health director-general Dr Noor Hisham Abdullah said the approval was made at the 383rd Drug Control Authority (DCA) meeting which convened yesterday (April 6).